SARS-CoV-2 Antibody Responses in Infection-Naive or Previously Infected Individuals After 1 and 2 Doses of the BNT162b2 Vaccine

This cohort study examines antibody responses in infection-naive and previously infected individuals after 1 and 2 doses of the BNT162b2 vaccine.

Detalles Bibliográficos
Autores principales: Anderson, Mark, Stec, Michael, Rewane, Ayesan, Landay, Alan, Cloherty, Gavin, Moy, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346938/
https://www.ncbi.nlm.nih.gov/pubmed/34357399
http://dx.doi.org/10.1001/jamanetworkopen.2021.19741
Descripción
Sumario:This cohort study examines antibody responses in infection-naive and previously infected individuals after 1 and 2 doses of the BNT162b2 vaccine.

Ejemplares similares